Long COVID has emerged as a complex challenge for global healthcare and economic systems. Unlike the acute phase of the pandemic, which caused an immediate macroeconomic shock, Long COVID exerts sustained, cumulative, and long-term structural pressure on national healthcare systems, economic development, and labor market dynamics. According to the latest research projections from the Organization for Economic Co-operation and Development (OECD), this negative impact will persist over the next decade. Furthermore, the bulk of the economic burden will be driven by indirect losses, significantly exceeding direct medical expenditures.
Analysis of Direct Medical Costs
The direct economic burden is primarily localized within the healthcare sector, encompassing costs for hospitalization, outpatient services, diagnostic testing, and pharmacological treatment. Empirical data confirms that expenses incurred for patients with Long COVID are, on average, 40–100% higher than those for individuals without post-viral complications.
For instance, an analysis of insurance claims for 277,000 adults in the US revealed that medical costs in the year following infection averaged $30,400, compared to $21,000 in the control group—a surplus cost of $9,400 per patient per year (+45%). Similar trends are observed elsewhere:
-
Israel: Monthly patient costs increased by 70–90% in the 4–12 month post-infection interval, while inpatient costs nearly doubled.
-
European Union: Direct medical costs per patient reach approximately €4,000–€5,000 annually, two to three times higher than for those without Long COVID.
At the macroeconomic level, cumulative expenditures already exceed hundreds of millions of euros, indicating that Long COVID is evolving into a financial burden comparable to chronic diseases.
Impact on the Labor Market and Productivity
Long COVID diminishes both the quantitative and qualitative indicators of human capital. This is reflected in reduced labor activity and productivity, which in turn hampers economic growth—particularly against the backdrop of labor shortages and demographic aging. The condition leads to frequent absenteeism, decreased efficiency at the workplace (presenteeism), and premature exit from the labor market. Statistically, one in five patients (20%) experiences a significant decline in work capacity, resulting in a 5–10% decrease in available labor resources during the first year of infection.
Labor market transformation is especially evident in specific countries:
-
United Kingdom: The probability of exiting the labor market 30–40 weeks after infection increased by 45%, with losses due to declining productivity reaching £5.7 billion.
-
Belgium and the US: Labor force exit rates have risen by 13% compared to the pre-pandemic period.
This process has hit the healthcare, education, and service sectors particularly hard. In the long term, such erosion of human capital will result in colossal financial losses for developed economies.
Fiscal Imbalance and Management Strategies
Long COVID significantly increases fiscal pressure on states. On one hand, expenditures on social protection, rehabilitation, and disability support are rising. On the other hand, tax revenues are notably decreasing due to falling employment levels. This double-sided pressure disrupts fiscal balance, increases budget deficits, and limits governments’ room for fiscal maneuver, especially in countries where social protection systems are already structurally overburdened.
At the policy level, the primary challenge remains a lack of institutional and cross-sectoral coordination. While specific state programs are active in some OECD countries, most lack a comprehensive national strategy for managing Long COVID. The structural gap between healthcare, labor market, and social protection policies is particularly problematic, leading to fragmentation in the response process. Countries utilizing integrated, multi-sectoral approaches (such as Germany and the Netherlands) have achieved far more effective results.
Projections and Future Costs
At the peak of the pandemic, more than 5% of the population in OECD countries (approximately 75 million people) developed Long COVID, driving total healthcare expenditures up to $53 billion. Specialists project that by 2025–2035, the prevalence of the condition will stabilize at around 1%.
Despite the slowing rate of spread, direct medical costs will remain high at approximately $11 billion annually. Furthermore, losses caused by declining labor productivity are expected to reach $135 billion, representing a 0.2% decrease in global GDP.
Forecasting Model and Conclusion
To evaluate the economic effects of Long COVID, the OECD Secretariat developed a dynamic epidemiological-economic model (OECD SPHeP framework). This model defines the scale of the disease’s spread and its impact on GDP dynamics for the period of 2020–2035. The research methodology relies on 2020–2023 mortality rates, ensuring the validity of the baseline assessments.
In conclusion, Long COVID has transformed from a clinical condition into a macroeconomic deterrent. Consequently, an effective response requires integrated, evidence-based policies that simultaneously improve the quality of patient care, facilitate their reintegration into the labor market, and minimize long-term economic damage.
